Skip to main content
Erschienen in: Current Urology Reports 5/2014

01.05.2014 | New Imaging Techniques (A Atala and A Rastinehad, Section Editors)

Pelvic Ultrasound Evaluation for Benign Prostatic Hyperplasia: Prediction of Obstruction

verfasst von: Daniel B. Rukstalis

Erschienen in: Current Urology Reports | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Global improvements in water quality, management of infectious diseases, and other medical therapeutics have resulted in a growing population of healthy aging men. One obligate anatomic consequence of aging for these men is the development of benign prostatic hyperplasia (BPH) with secondary bladder outlet obstruction. Although the voiding symptoms associated with the change in bladder health over time predominantly impact the quality of a man’s daily experience, there are also significant medical consequences of BPH that require intervention. It is a challenge to distinguish men who are at risk for these medical consequences from the much larger population of older men with voiding symptoms (lower urinary tract symptoms, LUTS). A variety of national guidelines have been developed to establish a diagnostic paradigm for meeting this challenge, but all suffer from inadequate sensitivity for the early identification of men at risk for permanent bladder injury. It is likely that the application of a thorough pelvic ultrasound designed to identify the pertinent anatomic aspects of both the bladder and prostate will improve the sensitivity of these diagnostic paradigms, with subsequent improvement in the outcomes for men with BPH/LUTS.
Literatur
1.
Zurück zum Zitat Arrighi HM et al. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore longitudinal study of aging. Urology. 1991;38(1 Suppl):4–8.PubMedCrossRef Arrighi HM et al. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore longitudinal study of aging. Urology. 1991;38(1 Suppl):4–8.PubMedCrossRef
2.
Zurück zum Zitat Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991;338(8765):469–71.PubMedCrossRef Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991;338(8765):469–71.PubMedCrossRef
3.••
Zurück zum Zitat Carballido J, et al. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial. Int J Clin Pract. 2009;63(8):1192-7. The majority of men with BPH/LUTS are likely to present to their primary care physicians prior to receiving a urologic consultation. This report details a possible evaluation pathway for primary physicians. Carballido J, et al. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial. Int J Clin Pract. 2009;63(8):1192-7. The majority of men with BPH/LUTS are likely to present to their primary care physicians prior to receiving a urologic consultation. This report details a possible evaluation pathway for primary physicians.
4.
5.
Zurück zum Zitat Toguri A, Barkin J. Management of benign prostatic hyperplasia by family physicians. Can J Urol. 2010;17 Suppl 1:26–34.PubMed Toguri A, Barkin J. Management of benign prostatic hyperplasia by family physicians. Can J Urol. 2010;17 Suppl 1:26–34.PubMed
6.
Zurück zum Zitat Collins MM et al. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians. J Gen Intern Med. 1997;12(4):224–9.PubMedCentralPubMed Collins MM et al. Diagnosis and treatment of benign prostatic hyperplasia. Practice patterns of primary care physicians. J Gen Intern Med. 1997;12(4):224–9.PubMedCentralPubMed
7.
Zurück zum Zitat Collins MM, O'Leary MP, Barry MJ. Prevalence of bothersome genitourinary symptoms and diagnoses in younger men on routine primary care visits. Urology. 1998;52(3):422–7.PubMedCrossRef Collins MM, O'Leary MP, Barry MJ. Prevalence of bothersome genitourinary symptoms and diagnoses in younger men on routine primary care visits. Urology. 1998;52(3):422–7.PubMedCrossRef
8.
Zurück zum Zitat Yafi FA et al. Are men on 5alpha-reductase inhibitors appropriately referred to urology? A survey of primary care physicians. BJU Int. 2011;108(8):1269–73.PubMedCrossRef Yafi FA et al. Are men on 5alpha-reductase inhibitors appropriately referred to urology? A survey of primary care physicians. BJU Int. 2011;108(8):1269–73.PubMedCrossRef
9.
Zurück zum Zitat Miner MM. Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ? Curr Urol Rep. 2009;10(4):254–60.PubMedCrossRef Miner MM. Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ? Curr Urol Rep. 2009;10(4):254–60.PubMedCrossRef
10.
Zurück zum Zitat Flanigan RC et al. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol. 1998;160(1):12–6. discussion 16-7.PubMed Flanigan RC et al. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol. 1998;160(1):12–6. discussion 16-7.PubMed
11.
Zurück zum Zitat McSherry J, Weiss R. Managing benign prostatic hyperplasia in primary care. Patient-centred approach. Can Fam Physician. 2000;46:383–9.PubMedCentralPubMed McSherry J, Weiss R. Managing benign prostatic hyperplasia in primary care. Patient-centred approach. Can Fam Physician. 2000;46:383–9.PubMedCentralPubMed
12.
Zurück zum Zitat Tejido-Sanchez A et al. Implementing an action protocol on prostatic disease in primary care and impact on referrals to urology. Arch Esp Urol. 2012;65(8):737–44.PubMed Tejido-Sanchez A et al. Implementing an action protocol on prostatic disease in primary care and impact on referrals to urology. Arch Esp Urol. 2012;65(8):737–44.PubMed
13.
Zurück zum Zitat Sausville J, Naslund M. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians. Int J Clin Pract. 2010;64(13):1740–5.PubMedCrossRef Sausville J, Naslund M. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians. Int J Clin Pract. 2010;64(13):1740–5.PubMedCrossRef
14.
Zurück zum Zitat Castineiras Fernandez J et al. Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Espanola de Medicos de Atencion Primaria, Sociedad Espanola de Medicina General, Sociedad Espanola de Medicina de Familia y Comunitaria, Asociacion Espanola de Urologia. Actas Urol Esp. 2010;34(1):24–34.PubMedCrossRef Castineiras Fernandez J et al. Referral criteria for benign prostatic hyperplasia in primary care.Sociedad Espanola de Medicos de Atencion Primaria, Sociedad Espanola de Medicina General, Sociedad Espanola de Medicina de Familia y Comunitaria, Asociacion Espanola de Urologia. Actas Urol Esp. 2010;34(1):24–34.PubMedCrossRef
15.
Zurück zum Zitat Fourcade RO et al. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries. BJU Int. 2008;101(9):1111–8.PubMedCrossRef Fourcade RO et al. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries. BJU Int. 2008;101(9):1111–8.PubMedCrossRef
16.
Zurück zum Zitat Costa P et al. Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients. Prog Urol. 2004;14(1):33–9.PubMed Costa P et al. Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients. Prog Urol. 2004;14(1):33–9.PubMed
17.
Zurück zum Zitat Carballido J et al. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial. Int J Clin Pract. 2011;65(9):989–96.PubMedCrossRef Carballido J et al. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial. Int J Clin Pract. 2011;65(9):989–96.PubMedCrossRef
18.••
Zurück zum Zitat McVary KT, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-803. The American Urologic Association has developed a comprehensive guideline for the diagnosis and management of BPH/LUTS that establishes an important platform for future innovation. McVary KT, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol. 2011;185(5):1793-803. The American Urologic Association has developed a comprehensive guideline for the diagnosis and management of BPH/LUTS that establishes an important platform for future innovation.
19.
Zurück zum Zitat Abrams P et al. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013;189(1 Suppl):S93–S101.PubMedCrossRef Abrams P et al. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013;189(1 Suppl):S93–S101.PubMedCrossRef
20.
Zurück zum Zitat Barry MJ et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57. discussion 1564.PubMed Barry MJ et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57. discussion 1564.PubMed
21.
Zurück zum Zitat Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol. 1993;150(5 Pt 2):1706–8. discussion 1708-9.PubMed Chancellor MB, Rivas DA. American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J Urol. 1993;150(5 Pt 2):1706–8. discussion 1708-9.PubMed
22.
Zurück zum Zitat Chancellor MB et al. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction. Br J Urol. 1994;74(2):200–3.PubMedCrossRef Chancellor MB et al. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction. Br J Urol. 1994;74(2):200–3.PubMedCrossRef
23.
Zurück zum Zitat Nitti VW, Kim Y, Combs AJ. Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn. 1994;13(5):521–7. discussion 527-9.PubMedCrossRef Nitti VW, Kim Y, Combs AJ. Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn. 1994;13(5):521–7. discussion 527-9.PubMedCrossRef
24.
Zurück zum Zitat Roehrborn CG. The assessment of patient complaints. Prog Clin Biol Res. 1994;386:73–96.PubMed Roehrborn CG. The assessment of patient complaints. Prog Clin Biol Res. 1994;386:73–96.PubMed
25.
Zurück zum Zitat Welch G et al. Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study. Urology. 1998;51(3):422–7.PubMedCrossRef Welch G et al. Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study. Urology. 1998;51(3):422–7.PubMedCrossRef
26.
Zurück zum Zitat Stenner J et al. Prevalence and natural history of urinary symptoms in a longitudinal national prostate cancer screening (community-based) study. Prostate Cancer Prostatic Dis. 1998;1(5):256–61.PubMedCrossRef Stenner J et al. Prevalence and natural history of urinary symptoms in a longitudinal national prostate cancer screening (community-based) study. Prostate Cancer Prostatic Dis. 1998;1(5):256–61.PubMedCrossRef
27.
Zurück zum Zitat de la Rosette JJ et al. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study. Neurourol Urodyn. 1998;17(2):99–108.PubMedCrossRef de la Rosette JJ et al. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study. Neurourol Urodyn. 1998;17(2):99–108.PubMedCrossRef
28.
29.
Zurück zum Zitat Rosario DJ et al. A comparison of ambulatory and conventional urodynamic studies in men with borderline outlet obstruction. BJU Int. 1999;83(4):400–9.PubMedCrossRef Rosario DJ et al. A comparison of ambulatory and conventional urodynamic studies in men with borderline outlet obstruction. BJU Int. 1999;83(4):400–9.PubMedCrossRef
30.
Zurück zum Zitat Reynard JM et al. The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol. 1998;82(5):619–23.PubMedCrossRef Reynard JM et al. The ICS-'BPH' Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol. 1998;82(5):619–23.PubMedCrossRef
31.
Zurück zum Zitat Golomb J et al. Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J Urol. 1992;147(4):1044–7.PubMed Golomb J et al. Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls. J Urol. 1992;147(4):1044–7.PubMed
32.
Zurück zum Zitat Mainprize TC, Drutz HP. Accuracy of total bladder volume and residual urine measurements: comparison between real-time ultrasonography and catheterization. Am J Obstet Gynecol. 1989;160(4):1013–6.PubMedCrossRef Mainprize TC, Drutz HP. Accuracy of total bladder volume and residual urine measurements: comparison between real-time ultrasonography and catheterization. Am J Obstet Gynecol. 1989;160(4):1013–6.PubMedCrossRef
33.
Zurück zum Zitat Granados EA, Escobar MR, Alcahe R. The use of transabdominal ultrasound in the estimation of postmicturitional residual urine. Arch Esp Urol. 1998;51(5):473–6.PubMed Granados EA, Escobar MR, Alcahe R. The use of transabdominal ultrasound in the estimation of postmicturitional residual urine. Arch Esp Urol. 1998;51(5):473–6.PubMed
34.
Zurück zum Zitat Alnaif B, Drutz HP. The accuracy of portable abdominal ultrasound equipment in measuring postvoid residual volume. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(4):215–8.PubMed Alnaif B, Drutz HP. The accuracy of portable abdominal ultrasound equipment in measuring postvoid residual volume. Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(4):215–8.PubMed
35.
Zurück zum Zitat Madersbacher S et al. The aging lower urinary tract: a comparative urodynamic study of men and women. Urology. 1998;51(2):206–12.PubMedCrossRef Madersbacher S et al. The aging lower urinary tract: a comparative urodynamic study of men and women. Urology. 1998;51(2):206–12.PubMedCrossRef
36.
Zurück zum Zitat Blanker MH et al. Voided volumes: normal values and relation to lower urinary tract symptoms in elderly men, a community-based study. Urology. 2001;57(6):1093–8. discussion 1098-9.PubMedCrossRef Blanker MH et al. Voided volumes: normal values and relation to lower urinary tract symptoms in elderly men, a community-based study. Urology. 2001;57(6):1093–8. discussion 1098-9.PubMedCrossRef
37.
Zurück zum Zitat McNeill SA et al. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin. Urology. 2001;57(3):459–65.PubMedCrossRef McNeill SA et al. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin. Urology. 2001;57(3):459–65.PubMedCrossRef
38.
Zurück zum Zitat Memon A, Ather MH. Use of residual fraction instead of residual volume in the evaluation of lower urinary tract symptoms. Tech Urol. 2000;6(1):26–8.PubMed Memon A, Ather MH. Use of residual fraction instead of residual volume in the evaluation of lower urinary tract symptoms. Tech Urol. 2000;6(1):26–8.PubMed
39.
Zurück zum Zitat Kok ET et al. Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men. Eur Urol. 2006;50(4):811–7.PubMed Kok ET et al. Determinants of seeking of primary care for lower urinary tract symptoms: the Krimpen study in community-dwelling men. Eur Urol. 2006;50(4):811–7.PubMed
40.
Zurück zum Zitat Dietz HP et al. Determination of postvoid residual by translabial ultrasound. Int Urogynecol J. 2012;23(12):1749–52.PubMedCrossRef Dietz HP et al. Determination of postvoid residual by translabial ultrasound. Int Urogynecol J. 2012;23(12):1749–52.PubMedCrossRef
41.
Zurück zum Zitat Ohnishi K et al. Development and clinical significance of protrusion of hypertrophic prostate into the bladder observed by transrectal ultrasonotomography. Nippon Hinyokika Gakkai Zasshi. 1985;76(8):1194–200.PubMed Ohnishi K et al. Development and clinical significance of protrusion of hypertrophic prostate into the bladder observed by transrectal ultrasonotomography. Nippon Hinyokika Gakkai Zasshi. 1985;76(8):1194–200.PubMed
42.
Zurück zum Zitat Chia SJ et al. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91(4):371–4.PubMedCrossRef Chia SJ et al. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91(4):371–4.PubMedCrossRef
43.
Zurück zum Zitat Dicuio M et al. The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies. Arch Ital Urol Androl. 2005;77(1):50–3.PubMed Dicuio M et al. The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies. Arch Ital Urol Androl. 2005;77(1):50–3.PubMed
44.
Zurück zum Zitat Yuen JS et al. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int J Urol. 2002;9(4):225–9.PubMedCrossRef Yuen JS et al. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int J Urol. 2002;9(4):225–9.PubMedCrossRef
45.
Zurück zum Zitat Lim KB et al. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol. 2006;13(12):1509–13.PubMedCrossRef Lim KB et al. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int J Urol. 2006;13(12):1509–13.PubMedCrossRef
46.••
Zurück zum Zitat Doo CK, Uh HS. Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS. Urology. 2009;73(2):232-6. This report illustrates the ultrasound anatomy of the prostate that is most associated with bladder outlet obstruction as a potential diagnostic tool. Doo CK, Uh HS. Anatomic configuration of prostate obtained by noninvasive ultrasonography can predict clinical voiding parameters for determining BOO in men with LUTS. Urology. 2009;73(2):232-6. This report illustrates the ultrasound anatomy of the prostate that is most associated with bladder outlet obstruction as a potential diagnostic tool.
47.
Zurück zum Zitat Huang T et al. Transitional zone index and intravesical prostatic protrusion in benign prostatic hyperplasia patients: correlations according to treatment received and other clinical data. Korean J Urol. 2012;53(4):253–7.PubMedCentralPubMedCrossRef Huang T et al. Transitional zone index and intravesical prostatic protrusion in benign prostatic hyperplasia patients: correlations according to treatment received and other clinical data. Korean J Urol. 2012;53(4):253–7.PubMedCentralPubMedCrossRef
48.
Zurück zum Zitat Wang D, Foo KT. Staging of benign prostate hyperplasia is helpful in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia. Ann Acad Med Singap. 2010;39(10):798–802.PubMed Wang D, Foo KT. Staging of benign prostate hyperplasia is helpful in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasia. Ann Acad Med Singap. 2010;39(10):798–802.PubMed
49.
Zurück zum Zitat Bhomi KK, Bhattachan CL. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Nepal Med Coll J. 2011;13(3):178–81.PubMed Bhomi KK, Bhattachan CL. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Nepal Med Coll J. 2011;13(3):178–81.PubMed
50.••
Zurück zum Zitat Park HY, et al. Efficacy of alpha blocker treatment according to the degree of intravesical prostatic protrusion detected by transrectal ultrasonography in patients with benign prostatic hyperplasia. Korean J Urol. 2012;53(2):92-7. The authors describe a clinical analysis that links the ultrasound appearance of the bladder and prostate to the clinical response of medical therapy. Park HY, et al. Efficacy of alpha blocker treatment according to the degree of intravesical prostatic protrusion detected by transrectal ultrasonography in patients with benign prostatic hyperplasia. Korean J Urol. 2012;53(2):92-7. The authors describe a clinical analysis that links the ultrasound appearance of the bladder and prostate to the clinical response of medical therapy.
51.
Zurück zum Zitat Manieri C et al. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol. 1998;159(3):761–5.PubMed Manieri C et al. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol. 1998;159(3):761–5.PubMed
52.
Zurück zum Zitat Hakenberg OW et al. Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement. Neurourol Urodyn. 2000;19(5):585–93.PubMedCrossRef Hakenberg OW et al. Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement. Neurourol Urodyn. 2000;19(5):585–93.PubMedCrossRef
53.
Zurück zum Zitat Salinas Casado J et al. Correlation of bladder thickness on ultrasound with clinical and urodynamic data in symptomatic benign prostatic hyperplasia. Arch Esp Urol. 2010;63(6):441–53.PubMedCrossRef Salinas Casado J et al. Correlation of bladder thickness on ultrasound with clinical and urodynamic data in symptomatic benign prostatic hyperplasia. Arch Esp Urol. 2010;63(6):441–53.PubMedCrossRef
54.
Zurück zum Zitat Eghbali K, Shayegan MR, Kianoush S. Investigating the effect of tamsulosin on the measurement of bladder wall thickness and International Prostate Symptom Score in benign prostatic hyperplasia. Can Urol Assoc J. 2013;7(5–6):E317–21.PubMedCentralPubMed Eghbali K, Shayegan MR, Kianoush S. Investigating the effect of tamsulosin on the measurement of bladder wall thickness and International Prostate Symptom Score in benign prostatic hyperplasia. Can Urol Assoc J. 2013;7(5–6):E317–21.PubMedCentralPubMed
55.
Zurück zum Zitat Kojima M et al. Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report. Urology. 1996;47(6):942–7.PubMedCrossRef Kojima M et al. Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report. Urology. 1996;47(6):942–7.PubMedCrossRef
56.
Zurück zum Zitat Inui E et al. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls. J Urol. 1999;161(3):827–30.PubMed Inui E et al. Comparative morphometric study of bladder detrusor between patients with benign prostatic hyperplasia and controls. J Urol. 1999;161(3):827–30.PubMed
57.
Zurück zum Zitat Akino H et al. Ultrasound-estimated bladder weight predicts risk of surgery for benign prostatic hyperplasia in men using alpha-adrenoceptor blocker for LUTS. Urology. 2008;72(4):817–20.PubMedCrossRef Akino H et al. Ultrasound-estimated bladder weight predicts risk of surgery for benign prostatic hyperplasia in men using alpha-adrenoceptor blocker for LUTS. Urology. 2008;72(4):817–20.PubMedCrossRef
58.
Zurück zum Zitat Egilmez T et al. Effects of selective alpha-1-adrenergic receptor blockers on bladder weight. Urol Int. 2006;76(1):42–50.PubMedCrossRef Egilmez T et al. Effects of selective alpha-1-adrenergic receptor blockers on bladder weight. Urol Int. 2006;76(1):42–50.PubMedCrossRef
Metadaten
Titel
Pelvic Ultrasound Evaluation for Benign Prostatic Hyperplasia: Prediction of Obstruction
verfasst von
Daniel B. Rukstalis
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Current Urology Reports / Ausgabe 5/2014
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-014-0403-8

Weitere Artikel der Ausgabe 5/2014

Current Urology Reports 5/2014 Zur Ausgabe

Minimally Invasive Surgery (V Bird and M Desai, Section Editors)

Robotic Surgery in Pediatric Urology

Minimally Invasive Surgery (V Bird and M Desai, Section Editors)

Kidney Stone Risk Following Modern Bariatric Surgery

Minimally Invasive Surgery (V Bird and M Desai, Section Editors)

Ureteroscopy for Treatment of Upper Urinary Tract Stones in Children: Technical Considerations

New Imaging Techniques (A Atala and A Rastinehad, Section Editors)

Emerging Endoscopic Imaging Technologies for Bladder Cancer Detection

Men's Health (R Carrion and C Yang, Section Editors)

Alternative Sexualities: Implications for the Urologist

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.